HIGHLIGHTS
- What: In the present review, a brief overview on the current status of such profibrotic activity-targeting PET radiotracers in cardiovascular disease is provided.
- Who: Takahiro Higuchi MD and PhD from the (UNIVERSITY) have published the research work: FAPI-PET in Cardiovascular Disease, in the Journal: (JOURNAL)
- Future: As radiotracers are administered systemically future studies may also focus on applications beyond cardiovascular disease to investigate bilateral organ function e_g fibrotic changes along the cardiorenal axis in patients after MI.
SUMMARY
Hile the concept of disturbed coronary artery flow in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.